Insulin price caps, Gold marketing

Air Date:
Heard On Central Time
insulin being put into a needle
Reed Saxon/AP Photo

A UW-Madison researcher looks at the practical impact of insulin price caps put in place by the federal government. Then, we learn more about how gold investment companies market toward customers on specific media outlets.

Featured in this Show

  • How 'gold IRAs' are marketed on conservative television, podcasts, and Facebook

    A data reporter shares some of his findings about gold investment companies that have advertised extensively on conservative and right-wing media platforms over the years, and even decades — and how they’ve fought legal challenges over some of their operations.

  • How are price caps affecting insulin costs?

    A new study found out-of-pocket insulin costs for Americans on Medicare totaled over $1 billion in 2020. That’s more than quadruple the cost in 2007. Through the 2022 Inflation Reduction Act, the Biden Administration in January capped the out-of-pocket cost insulin to $35 a month. We talk with the UW-Madison assistant professor behind the study about the effects of price caps on insulin costs.

Episode Credits

  • Rob Ferrett Host
  • Tyler Ditter Technical Director
  • Tim Peterson Producer
  • Royce Podeszwa Producer
  • Jeremy B. Merrill Guest
  • Rebecca Myerson Guest

Related Stories